Member Sign In
Member Sign Out
Drug Discovery & Development
Non-psychedelic compound has similar antidepressant effect as psychedelics in mice
September 29, 2022 --
Researchers have developed a new non-psychedelic compound that hits the same brain cell target as psychedelic drugs, triggering lasting antidepressant effects in mice but without hallucinations.
Heart medication spironolactone may also treat alcohol use disorder
September 21, 2022 --
Spironolactone, a diuretic medication used for heart problems and high blood pressure, may also effectively treat alcohol use disorder by reducing consumption, according to a new study published September 20 in the journal
Beckman Coulter acquires biotech company ValitaCell in analytics play
September 16, 2022 --
Laboratory automation company Beckman Coulter Life Sciences has acquired biotech company ValitaCell for an undisclosed amount, according to a September 13 announcement from the companies.
Federal funding of $2B to support biotechnology and biomanufacturing
September 14, 2022 --
The White House announced on Wednesday federal funding of more than $2 billion to advance President Joe Biden’s executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing.
Women researchers in life sciences face gender inequities in mentoring
September 9, 2022 --
There is a disproportionate tendency for women to leave academic research instead of advancing to positions in which they become mentors themselves, according to an analysis of formal PhD and postdoctoral mentoring relationships in the life sciences.
Scientists find link between chronic pain and lung cancer in mice, offers hope for chronic pain
September 1, 2022 --
A new study points to potential new treatments for chronic pain by targeting the metabolite tetrahydrobiopterin (BH4). The therapeutic pathway could improve chronic pain management and combat the opioid epidemic.
Cell culture, mouse studies offer potential new targets for cancer treatments
August 30, 2022 --
University of Gothenburg scientists have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice, potentially enabling future development of new drugs targeted at a range of cancers.
University of Chicago, Kansas awarded $1.2M to transform understanding of RNA splicing
August 29, 2022 --
The W.M. Keck Foundation has awarded a $1.2 million grant to researchers at the University of Chicago and the University of Kansas to help identify human gene sequences that will respond to drug therapies.
Bio-Rad offers antievolocumab antibodies for preclinical, clinical drug development
August 25, 2022 --
Bio-Rad Laboratories is now offering a range of antievolocumab antibodies approved for in vitro research purposes and for commercial in vitro testing services to support preclinical and clinical drug development.
Animal studies provide new insights into mechanisms behind Crohn’s disease
August 22, 2022 --
Researchers, led by Massachusetts General Hospital, have found that inhibitors of an enzyme called Speckled Protein 140 can reverse intestinal abnormalities in mice with inflammation characteristic of Crohn's disease.
Laboratory Products Association Annual Meeting
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
Carlsbad, California United States
American Association of Pharmaceutical Scientists PharmSci 360 Annual Meeting
Boston, Massachusetts United States
District of Columbia United States
American Society of Human Genetics Annual Meeting
Los Angeles, California United States
More Conferences »»
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard